Sg3 Management, LLC Bristol Myers Squibb CO Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $44,505 - $50,054	-750 Reduced 75.0%	250 $16,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $5,743 - $6,364	100 Added 11.11%	1,000 $60,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $1.11 Million - $1.29 Million	-20,200 Reduced 95.73%	900 $53,000
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $51,040 - $74,173	1,100 Added 5.5%	21,100 $1.18 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $984,200 - $1.28 Million	20,000 New	20,000 $1.28 Million
Q2 2018 Aug 02, 2018	SELL	$50.53 - $62.98 $2.27 Million - $2.83 Million	-45,000 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $2.7 Million - $3.1 Million	45,000 New	45,000 $2.85 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.